In comparison to the WT-T2DM group, the KO-T2DM group exhibited markedly lower levels of TNF-α, IL-17, and IL-23 (P < 0.05, P < 0.05, and P < 0.01, respectively). This evidence concerns the gene IL17A and type 2 diabetes mellitus.